Podcast | The Practice of Medicine | March 29, 2021

Prophylactic Transfusion during Pregnancy for Women with Sickle Cell Disease

In this podcast, Dr. Everett Magann discusses prophylactic transfusion during pregnancy for women with sickle cell disease. Dr. Magann is the corresponding author of an article appearing in the April 2021 issue of the Southern Medical Journal that addresses this topic.

Dr EF Magann is currently the Fellowship Director of the Maternal-Fetal Medicine (MFM) department at University of Arkansas for Medical Sciences, and the senior departmental MFM.  He holds the position as Associate Editor in Chief of, The International Journal of Women’s Health, and is an editor of the Journal of Maternal-Fetal and Neonatal Medicine.  As a retired Navy Captain, he is the Vice Chair of the Armed Forces District of ACOG, and has published more than 376 peer review articles and has authored 43 book chapters.

References and Resources

  1. Whittington JR, Magann EF, Ounpraseuth ST, et al. Evidence for prophylactic transfusion during pregnancy for women with sickle cell disease. South Med J 2021;114:231-236.
  2. Okusanya BO, Oladapo OT. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. Cochrane Database Syst Rev 2016;12: CD010378.
  3. Asma S, Kozanoglu I, Tarim E, et al. Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy. Transfusion 2015;55:36–44.
  4. Howard J, Malfroy M., Llewelyn C, et al. The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomized, controlled, multicenter clinical trial. Lancet 2013;381:930–998